Mimedx (MDXG) Net Cash Flow (2011 - 2026)

Mimedx has disclosed Net Cash Flow across 16 years of filings, most recently posting -$6.3 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$6.3 million, down 415.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.3 million (down 9.4% YoY), and the FY2025 annual result was $61.7 million, up 164.31% from the prior year.
• Net Cash Flow came in at -$6.3 million for Q1 2026 at Mimedx, down from $24.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $24.0 million in Q4 2025 to a low of -$33.5 million in Q1 2024.
• The 5-year median for Net Cash Flow is $2.7 million (2022), against an average of $4.9 million.
• Across the five-year window, Net Cash Flow plunged 1316.09% in 2022 and jumped 1879.07% in 2024, its largest moves.
• Mimedx's Net Cash Flow stood at $2.7 million in 2022, then tumbled by 68.5% to $836000.0 in 2023, then surged by 1879.07% to $16.5 million in 2024, then surged by 45.29% to $24.0 million in 2025, then slumped by 126.41% to -$6.3 million in 2026.
• The last three Net Cash Flow figures came in at -$6.3 million (Q1 2026), $24.0 million (Q4 2025), and $23.2 million (Q3 2025), per Business Quant data.